Kmk-Clinicalsp. z o.o.

Paramedical activities

KRS: NIP: REGON:

Overview

Status
Active
Registry date
2010-10-26
Share capital
10,000.00 PLN
Registered address
ul. Załęska 9, 40-571 Katowice, Poland
Electronic delivery address
AE:PL-23509-17930-HHDFA-16

Financials

Revenue history (in k)

Filing timeliness

1 of 6 financial statements was filed late (for 2021, 13 days late).

  • 202503/07/2026
  • 202401/07/2025
  • 202322/05/2024
  • 202221/06/2023
  • 202128/07/2022
  • 202011/08/2021
Filed on timeDelayFiling deadline

Data and insights are generated automatically from financial statements – they may contain errors and are neither a credit assessment nor business advice.

Statistics

How the company ranks by revenue within its industry, city, voivodeship and across Poland in 2025.

Industry · Paramedical activities24 / 273
Top 8.8%
Division · Human health activities772 / 2,927
Top 26%
Top 27%
City · Katowice2,537 / 6,170
Top 41%
Voivodeship · Śląskie15,184 / 33,279
Top 46%
Country · Poland135,382 / 297,935
Top 45%

Results vs industry

Revenue
This companyUSD 383.82kMedianUSD 38.50kAverageUSD 150.26k
Net profit
This companyUSD 87.41kMedianUSD 224.88AverageUSD 12.17k
Operating costs
This companyUSD 275.41kMedianUSD 38.91kAverageUSD 133.82k
Assets
This companyUSD 591.67kMedianUSD 17.01kAverageUSD 103.30k

National Health Fund (NFZ) contracts

Kmk-Clinical has been an NFZ healthcare provider since 2012. In 2026 it is performing 1 contract worth USD 2.33m. All its contracts were worth USD 18.02m in total.

NFZ contract value by year (in k USD)

Type of careNFZ branchContractsValue in 2026
Inpatient treatmentśląskie1USD 2.33m

NFZ waiting lists

This company's facilities run 5 NFZ waiting lists. Waiting time forecast by NFZ, as of 29.10.2026.

ServiceWaiting time
Treatment of patients with neuromyelitis optica spectrum disorder (NMOSD)no wait
Treatment of patients with neuromyelitis optica spectrum disorder (NMOSD)no wait
Treatment of patients with multiple sclerosis3 days
Treatment of patients with multiple sclerosis7 days
Treatment of patients with limb spasticity using botulinum toxin type A8 days

Authorized Representatives

Anna Gocek Maciejowska – President of the Management Board
Maciej Maciejowski – Attorney-in-fact (sole)

Manner of representation

If a one-person management board is appointed, the company is represented by the President of the Management Board independently. If a multi-member management board is appointed, joint action by two members of the management board is required to make declarations on behalf of the company.

Ownership

OwnerSharesShare valueStake
Anna Katarzyna Gocek Maciejowskaage 62
100$1,350.6250%
Katarzyna Anna Maciejowska
30$405.1915%
Maciej Maciejowskiage 62
70$945.4335%

Anna Katarzyna Gocek Maciejowska, Maciej Maciejowski and Katarzyna Anna Maciejowska hold a combined 100% – the ownership structure indicates family control.

Beneficial owners

Person

Debt

No entries in the National Debtors Register (KRZ).

MSiG notices

Publication dateEvent
Jan 8, 2013Liquidation opened

Public aid

No public aid cases recorded in the last 10 years.

Competitors

Name
Klinika Gorszewskasp. z o.o.
Kandarasp. z o.o.
Heliconsp. z o.o.
Onenesssp. z o.o.
Phtisp. z o.o.
Salvomed Kolumna Transportu Sanitarnegosp. z o.o.
Naturiana Paulina Szpakowska-Kurczynsp. z o.o.
21 Stópsp. z o.o.
Manuartissp. z o.o.
Namajasp. z o.o.

Change history

DateEvent
2022-12-07Share capital increase
2022-12-07PKD change
2018-03-26Address change
2013-04-26Address change
2010-10-26Entered in the register

FAQ

Last updated: 2026-07-06